EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Interactions of blood biomolecules with early rhythm control in atrial fibrillation patients: exploratory analysis of the EAST-AFNET 4 biomolecule study

Christoph Al-Taie iD, Julius Obergassel iD, Katrin Borof, Julius Ridder iD, Andreas Rillig iD, Andreas Metzner iD, Andreas Goette iD, Christina Magnussen iD, Moritz F Sinner iD, Laura C Sommerfeld iD, Stephan Willems iD, Tanja Zeller iD und 5 weitere

Europace · 2026

DOI: 10.1093/europace/euag149 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift Europace, 2026. Verfasst von Christoph Al-Taie und 16 weiteren Autor:innen. Beteiligte Einrichtung: University Centre of Cardiovascular Science, University Medical Center Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany. Hauptthemen laut MEDLINE: Anti-Arrhythmia Agents, Atrial Fibrillation, Heart Rate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Early Treatment of Atrial Fibrillation for Stroke Prevention Trial, German Ministry of Education and Research, DZHK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Early rhythm control reduces cardiovascular events in patients with atrial fibrillation (AF) and cardiovascular comorbidities. Whether this effect is consistent across severities of different AF-associated conditions is not known.

Methods

In the EAST-AFNET 4 biomolecule study (n = 1586; median age 70 years; 45% women), 14 circulating biomarkers reflecting inflammation, fibrosis, ageing, cardiac strain, and myocardial damage were quantified. Log-transformed, winsorized biomarkers were analysed in quintiles to detect non-linear associations and as continuous parameters. Cox proportional hazards models evaluated associations with the primary outcome (cardiovascular death, stroke, or unplanned hospitalization for heart failure or acute coronary syndrome) and the safety outcome (death, stroke, or major bleeding) of the trial, including interaction terms for biomarkers and randomized treatment [early rhythm control (ERC) vs. usual care (UC)]. Two independent cohorts, BBC-AF resembling UC and a TRUST snapshot resembling ERC were combined for external replication. All tests were exploratory.

Results

ERC reduced the primary outcome consistently across biomarker concentrations. No signal for treatment interaction was observed for 13 of 14 biomarkers for the primary outcome. For BMP10, a nominal interaction was observed in categorical analyses, suggesting an attenuated treatment effect of ERC in patients in the lowest BMP10 quintile. No interaction was detected for continuous parameters. Similar patterns were observed in exploratory analyses of the replication cohort.

Conclusion

ERC therapy is effective across patients with different severities of conditions associated with AF as quantified by biomolecule concentrations. A potentially attenuated effect of ERC with low BMP10 concentrations warrants further research. This analysis is part of the EAST-AFNET 4 trial biomolecule study, the original trial has been registered under the official title: Early Therapy of Atrial Fibrillation for Stroke Prevention Trial (EAST) (EudraCT 2010-021258-20) at https://clinicaltrials.gov/study/NCT01288352.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Arrhythmia AgentsAtrial FibrillationHeart RateAgedFemaleHumansMaleMiddle AgedAcute Coronary SyndromeBiomarkersHeart FailureRisk FactorsStrokeTime FactorsTreatment Outcome

Stichwörter der Autor:innen

Atrial fibrillationBMP10Cardiovascular biomarkersEarly rhythm controlInteraction analysis

Substanzen

Anti-Arrhythmia AgentsBiomarkers

Autor:innen und Institutionen

  • University Centre of Cardiovascular Science, University Medical Center Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany.
  • Department of Cardiology, University Heart and Vascular Centre Hamburg (UHZ), Martinistr. 52, 20246 Hamburg, Germany.
  • German Centre for Cardiovascular Research (DZHK), Partner Site North, Martinistr. 52, 20246 Hamburg, Germany.
  • Department of Cardiology and Intensive Care Medicine, Saint Vincenz Hospital Paderborn, Paderborn, Germany.
  • Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.
  • Atrial Fibrillation NETwork (AFNET), Mendelstr. 11, 48149 Münster, Germany.

ORCID-Profile: Christoph Al-Taie, Julius Obergassel, Julius Ridder, Andreas Rillig, Andreas Metzner, Andreas Goette, Christina Magnussen, Moritz F Sinner, Laura C Sommerfeld, Stephan Willems, Tanja Zeller, Renate B Schnabel, Ulrich Schotten, Antonia Zapf, Paulus Kirchhof, Larissa Fabritz

Förderung

  • Early Treatment of Atrial Fibrillation for Stroke Prevention Trial
  • German Ministry of Education and Research
  • DZHK
  • AFNET
  • EHRA
  • St. Jude Medical
  • Abbott
  • Sanofi

Zitieren

APA

Al-Taie, C., Obergassel, J., Borof, K., Ridder, J., Rillig, A., Metzner, A., Goette, A., Magnussen, C., Sinner, M. F., Sommerfeld, L. C., Willems, S., Zeller, T., Schnabel, R. B., Schotten, U., Zapf, A., Kirchhof, P., & Fabritz, L. (2026). Interactions of blood biomolecules with early rhythm control in atrial fibrillation patients: exploratory analysis of the EAST-AFNET 4 biomolecule study. Europace. https://doi.org/10.1093/europace/euag149

Vancouver

Al-Taie C, Obergassel J, Borof K, Ridder J, Rillig A, Metzner A, et al. Interactions of blood biomolecules with early rhythm control in atrial fibrillation patients: exploratory analysis of the EAST-AFNET 4 biomolecule study. Europace. 2026. doi:10.1093/europace/euag149

BibTeX
@article{AlTaie2026,
  author = {Al-Taie, Christoph and Obergassel, Julius and Borof, Katrin and Ridder, Julius and Rillig, Andreas and Metzner, Andreas and Goette, Andreas and Magnussen, Christina and Sinner, Moritz F and Sommerfeld, Laura C and Willems, Stephan and Zeller, Tanja and Schnabel, Renate B and Schotten, Ulrich and Zapf, Antonia and Kirchhof, Paulus and Fabritz, Larissa},
  title = {Interactions of blood biomolecules with early rhythm control in atrial fibrillation patients: exploratory analysis of the EAST-AFNET 4 biomolecule study},
  journal = {Europace},
  year = {2026},
  doi = {10.1093/europace/euag149}
}
Kostenlos starten →